-
Visit SAGE journals online journals.sagepub.com/ home/tam
-
C.
Chrystoja,
E.
Diamandis,
R.
Brand,
F.
Rückert,
R.
Haun,
R.
Molina
(2013)
Pancreatic cancer.
Clinical chemistry, 59 1
-
(2008)
Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis
, 28
-
D.
Vernerey,
F.
Huguet,
A.
Vienot,
D.
Goldstein,
S.
Paget‐Bailly,
J.
Laethem,
B.
Glimelius,
P.
Artru,
M.
Moore,
T.
André,
L.
Mineur,
B.
Chibaudel,
Magdalena
Benetkiewicz,
C.
Louvet,
P.
Hammel,
F.
Bonnetain
(2016)
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
British Journal of Cancer, 115
-
H.
Ueno,
S.
Okada,
T.
Okusaka,
M.
Ikeda
(2000)
Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy
Oncology, 59
-
Tadayuki
Kou,
M.
Kanai,
Michio
Yamamoto,
P.
Xue,
Y.
Mori,
Yasushi
Kudo,
A.
Kurita,
N.
Uza,
Y.
Kodama,
M.
Asada,
Michiya
Kawaguchi,
T.
Masui,
M.
Mizumoto,
S.
Yazumi,
S.
Matsumoto,
K.
Takaori,
S.
Morita,
M.
Muto,
S.
Uemoto,
T.
Chiba
(2016)
Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy
International Journal of Clinical Oncology, 21
-
E.
Veer,
L.
Rijssen,
M.
Besselink,
R.
Mali,
J.
Berlin,
S.
Boeck,
F.
Bonnetain,
I.
Chau,
T.
Conroy,
E.
Cutsem,
G.
Deplanque,
H.
Friess,
B.
Glimelius,
D.
Goldstein,
R.
Herrmann,
R.
Labianca,
J.
Laethem,
T.
Macarulla,
J.
Meer,
J.
Neoptolemos,
T.
Okusaka,
E.
O’Reilly,
U.
Pelzer,
U.
Pelzer,
P.
Philip,
M.
Poel,
M.
Reni,
W.
Scheithauer,
J.
Siveke,
C.
Verslype,
O.
Busch,
J.
Wilmink,
M.
Oijen,
H.
Laarhoven
(2018)
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.
The Lancet. Oncology, 19 3
-
H.
Park,
H.
Lee,
J.
Park,
Joon
Park,
D.
Lee,
Se-Joon
Lee,
D.
Yoon,
Min
Lee,
H.
Jeung
(2016)
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
Cancer Research and Treatment : Official Journal of Korean Cancer Association, 48
-
J.
Tabernero,
E.
Chiorean,
J.
Infante,
S.
Hingorani,
V.
Ganju,
C.
Weekes,
W.
Scheithauer,
R.
Ramanathan,
D.
Goldstein,
D.
Penenberg,
A.
Romano,
S.
Ferrara,
D.
Hoff
(2015)
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
The oncologist, 20 2
-
Mei
Geng,
HaoPing
Xu,
Ruobing
Ren,
Q.
Qu,
C.
Shangguan,
Junwei
Wu,
Jinsong
Jiang,
Hao
Li,
W.
Cao
(2015)
Prognostic value of clinicopathological characteristics in patients with pancreatic cancer.
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 27 5
-
N.
Tsavaris,
Ch.
Kosmas,
N.
Papadoniou,
P.
Kopteridis,
K.
Tsigritis,
A.
Dokou,
J.
Sarantonis,
H.
Skopelitis,
M.
Tzivras,
K.
Gennatas,
A.
Polyzos,
G.
Papastratis,
G.
Karatzas,
Alexandros
Papalambros
(2009)
CEA and CA-19.9 Serum Tumor Markers as Prognostic Factors in Patients with Locally Advanced (Unresectable) or Metastatic Pancreatic Adenocarcinoma: A Retrospective Analysis
Journal of Chemotherapy, 21
-
J.
Bernhard,
D.
Dietrich,
W.
Scheithauer,
D.
Gerber,
G.
Bodoky,
T.
Ruhstaller,
B.
Glimelius,
E.
Bajetta,
J.
Schüller,
P.
Saletti,
J.
Bauer,
A.
Figer,
B.
Pestalozzi,
C.
Köhne,
W.
Mingrone,
S.
Stemmer,
K.
Tamas,
G.
Kornek,
D.
Koeberle,
R.
Herrmann
(2008)
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 22
-
D.
Watt,
M.
Proctor,
J.
Park,
P.
Horgan,
D.
McMillan
(2015)
The Neutrophil-Platelet Score (NPS) Predicts Survival in Primary Operable Colorectal Cancer and a Variety of Common Cancers
PLoS ONE, 10
-
R.
Soest,
A.
Templeton,
A.
Templeton,
F.
Vera-Badillo,
Florence
Mercier,
G.
Sonpavde,
E.
Amir,
Bertrand
Tombal,
M.
Rosenthal,
M.
Eisenberger,
I.
Tannock,
R.
Wit
(2015)
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.
Annals of oncology : official journal of the European Society for Medical Oncology, 26 4
-
A.
Kasuga,
N.
Okano,
D.
Naruge,
H.
Kitamura,
A.
Takasu,
F.
Nagashima,
J.
Furuse
(2015)
Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival
Cancer Chemotherapy and Pharmacology, 75
-
Z.
Mei,
Lu
Shi,
Bo
Wang,
Jizhen
Yang,
Zhihong
Xiao,
Peixin
Du,
QingMing
Wang,
Wei
Yang
(2017)
Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Cancer treatment reviews, 58
-
V.
Hess,
B.
Glimelius,
Philipp
Grawe,
D.
Dietrich,
G.
Bodoky,
T.
Ruhstaller,
E.
Bajetta,
P.
Saletti,
A.
Figer,
W.
Scheithauer,
R.
Herrmann
(2008)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial.
The Lancet. Oncology, 9 2
-
G.
Luo,
M.
Guo,
Zuqiang
Liu,
Zhiwen
Xiao,
K.
Jin,
J.
Long,
Liang
Liu,
Chen
Liu,
Jin
Xu,
Q.
Ni,
Xianjun
Yu
(2014)
Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy
Annals of Surgical Oncology, 22
-
R.
Herrmann,
G.
Bodoky,
T.
Ruhstaller,
B.
Glimelius,
E.
Bajetta,
J.
Schüller,
P.
Saletti,
J.
Bauer,
A.
Figer,
B.
Pestalozzi,
C.
Köhne,
W.
Mingrone,
S.
Stemmer,
K.
Tamas,
G.
Kornek,
D.
Koeberle,
S.
Cina,
J.
Bernhard,
D.
Dietrich,
W.
Scheithauer
(2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 16
-
P.
Xue,
M.
Kanai,
Y.
Mori,
T.
Nishimura,
N.
Uza,
Y.
Kodama,
Y.
Kawaguchi,
K.
Takaori,
S.
Matsumoto,
S.
Uemoto,
T.
Chiba
(2014)
Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients
Cancer Medicine, 3